Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Free
Message: NYT article: Precautions Urged for Drivers With Diabetes

2 positive posts in a row?

Who stole OPC's body?

I agree with your assessment about the long term and would be very happy if you are correct. I have long thought what we need is the market to decide the success of Afrezza. Word of mouth when it comes to treatment. All someone has to do is notice somebody taking a little whiff sitting at a table in a restaurant and get a satisfied patient talking about the latest and greatest treatment for a very common malady and off we go.

I know many feel we need the support of a big pharma but I don't. I think with a streamlined salesforce, smart media buying and word of mouth the product catches fire and takes off at about the pace we can expand the manufacturing facility. $2,000/ year/ new patient adds up very quickly. Phase 4 study with 4 year olds and you get the entire JDRF community going.

Swing

Share
New Message
Please login to post a reply